CA1133495A - Cis et trans-3-aryloxy-4-hydroxypyrrolidines et derives - Google Patents

Cis et trans-3-aryloxy-4-hydroxypyrrolidines et derives

Info

Publication number
CA1133495A
CA1133495A CA343,328A CA343328A CA1133495A CA 1133495 A CA1133495 A CA 1133495A CA 343328 A CA343328 A CA 343328A CA 1133495 A CA1133495 A CA 1133495A
Authority
CA
Canada
Prior art keywords
trans
process according
pyrrolidinol
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA343,328A
Other languages
English (en)
Inventor
David A. Walsh
William J. Welstead, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AH Robins Co Inc
Original Assignee
AH Robins Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AH Robins Co Inc filed Critical AH Robins Co Inc
Application granted granted Critical
Publication of CA1133495A publication Critical patent/CA1133495A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
CA343,328A 1979-01-09 1980-01-09 Cis et trans-3-aryloxy-4-hydroxypyrrolidines et derives Expired CA1133495A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US215179A 1979-01-09 1979-01-09
US002,151 1979-01-09

Publications (1)

Publication Number Publication Date
CA1133495A true CA1133495A (fr) 1982-10-12

Family

ID=21699450

Family Applications (1)

Application Number Title Priority Date Filing Date
CA343,328A Expired CA1133495A (fr) 1979-01-09 1980-01-09 Cis et trans-3-aryloxy-4-hydroxypyrrolidines et derives

Country Status (9)

Country Link
JP (1) JPS5598160A (fr)
CA (1) CA1133495A (fr)
CH (1) CH643243A5 (fr)
DE (1) DE3000625A1 (fr)
FR (1) FR2446279B1 (fr)
GB (1) GB2040933B (fr)
IT (1) IT1127967B (fr)
MX (1) MX6634E (fr)
SE (1) SE435927B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45511B1 (en) 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
US4547514A (en) * 1983-12-05 1985-10-15 A. H. Robins Company, Incorporated Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity
JPS60178860A (ja) * 1984-02-24 1985-09-12 Sankyo Co Ltd ３−メルカプトピロリジンまたはその塩の製法
JPS6157552A (ja) * 1984-08-29 1986-03-24 Toyama Chem Co Ltd ３−アミノピロリジンまたはその塩の製法
DE3813416A1 (de) * 1988-04-21 1989-11-02 Hoechst Ag 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
EP0407701A3 (en) * 1989-05-15 1992-04-22 Fujisawa Pharmaceutical Co., Ltd. Antiretroviral pyrroline and pyrrolidine sulfonic acid derivatives
JP5323063B2 (ja) 2007-05-31 2013-10-23 塩野義製薬株式会社 オキシイミノ化合物およびその使用
EP2346820B1 (fr) 2008-06-11 2013-02-13 Shionogi & Co., Ltd. Composés oxycarbamoyle et leur utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1000308A (fr) * 1949-05-28 1952-02-11 Basf Ag Procédé pour la production de 3. 4-dioxypyrrolidines
FR1000310A (fr) * 1949-06-18 1952-02-11 Basf Ag Procédé pour la production de dérivés de pyrrolidine
FR1532221A (fr) * 1963-10-22 1968-07-12 Robins Co Inc A H Procédé de production de n, n-di (aryl monocarbocyclique)-carbamates de 1-(alkylinférieur)-3-pyrrolidyle
CH521338A (de) * 1967-03-13 1972-04-15 Robins Co Inc A H Verfahren zur Herstellung von neuen Pyrrolidinderivaten
US3577415A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-substituted phenoxypyrrolidines
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof

Also Published As

Publication number Publication date
FR2446279B1 (fr) 1985-10-31
CH643243A5 (fr) 1984-05-30
MX6634E (es) 1985-09-12
IT8067020A0 (it) 1980-01-08
DE3000625C2 (fr) 1989-04-20
JPS5598160A (en) 1980-07-25
GB2040933B (en) 1983-07-20
SE435927B (sv) 1984-10-29
DE3000625A1 (de) 1980-07-17
IT1127967B (it) 1986-05-28
SE8000085L (sv) 1980-08-26
JPS648621B2 (fr) 1989-02-14
FR2446279A1 (fr) 1980-08-08
GB2040933A (en) 1980-09-03

Similar Documents

Publication Publication Date Title
US4584293A (en) Aminotetralin derivatives
US3577432A (en) 1-substituted-3-phenoxypyrrolidines
US4360519A (en) Analgesic method using a morpholine compound
EP0096838A1 (fr) Aryloxy-1 tétrahydro-2,3,4,5 benzazépines-3, leur procédé de préparation et leur application comme médicaments
CA1133495A (fr) Cis et trans-3-aryloxy-4-hydroxypyrrolidines et derives
CA1103674A (fr) .alpha.-(3-AZETIDINYL)-.alpha.-PHENYLACETONITRILES ET ACETAMIDES
IE912760A1 (en) Compounds
CA1257277A (fr) Aryloxymethylpyrrolidinols et piperidinols ayant une activite antidepressive, antiarythmique et hypotensive
US4048314A (en) Morpholino containing 4-arylpiperidine derivatives
US5130309A (en) Aryloxy and aryloxyalklazetidines as antiarrhythmic and anticonvulsant agents
US4585785A (en) Cis and trans-3-aryloxy-4-hydroxypyrrolidines used as anti-arrhythmics
WO1999036398A1 (fr) Derives aminosulphonylbenzamides utilises comme inhibiteurs de l'activite des canaux calcium neuronaux
CA1155859A (fr) Carbamates, methode de preparation et compose pharmaceutiques les contenant
US4452809A (en) Trans-4-(2-chlorophenoxy)-1-ethyl-3-pyrrolidinol and anti-depressant use thereof
US4254135A (en) 3-Amino-4-hydroxypyrrolidines
US4139620A (en) 1-Substituted-3-aminoethoxypyrrolidines and use thereof
US3754003A (en) Tetramethyl pyrrolidine derivatives
US4652559A (en) 2-(Phenylmethylene)cycloalkyl-azetidines
CA1133912A (fr) 3-arylthio-4-hydroxy-pyrrolidines substituees en 1
JP3105135B2 (ja) 新規なベンゾスピロアルケン誘導体、それらの製造法 及びそれら誘導体を含有する製剤組成物
US4172143A (en) 2-Methoxy-benzamide derivatives
EP0008108B1 (fr) Dérivés aminopropanolés de 2-(o-hydroxyphényl)-pyrroles, procédé de préparation et compositions pharmaceutiques les contenant
JPS61210031A (ja) 抗けいれん剤および抗てんかん剤としての３‐アリルオキシアゼチジンカルボキサミド
US5095014A (en) 3-(2-chloro-4-(trifluoromethyl)phenoxy)-1-azetidine carboxamides having anticonvulsant activity
DD210266A5 (de) Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten

Legal Events

Date Code Title Description
MKEX Expiry